Is Sutro Biopharma, Inc. overvalued?

Sutro Biopharma, Inc. (STRO) — key valuation metrics and fundamentals.

No verdict

Price

$16.03

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$155.1M

Dividend yield

0.0%

Return on equity

185.3%

Sector

Healthcare

Fair value compares STRO's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks